All In Biotech

Drug Trial Radar · NCT00673309

Assessment of Mechanisms of Improved Wound Healing

Assessment of Mechanisms of Improved Wound Healing of Anabolic Agents and Diet in Severely Burned Patients

Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 644 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

644

Actual

Start

Jul 2000

Primary completion

Apr 2011

Study completion Apr 2013

Sponsor

Lead sponsor
The University of Texas Medical Branch, GalvestonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of General Medical Sciences (NIGMS)
First posted
May 7, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find ways to improve wound healing and decrease the negative effects of trauma from burn injury.

Conditions

  • Burns

Interventions

  • Stable Isotope Infusion studyProcedure

    Stable isotope infusion study to be done following each surgery. Tagged isotopes to assess uptake into blood and tissues. Includes collection of blood and tissues (muscle)

  • Insulin High DoseDrug

    Insulin IV administered continuously throughout hospitalization until wounds are 95% healed.

  • oxandroloneDrug

    Oxandrolone given daily throughout hospitalization until 95% wound healing.

  • PropranololDrug

    Propranolol to be given daily throughout hospitalization until 95% wound healing.

  • Growth HormoneDrug

    Recombinant Human Growth hormone to be administered daily until 95% wound healing.

  • Insulin Low DoseDrug

    Insulin administered IV until 95% wound healing

  • IGF-1/IGFBP-3Drug

    Insulin Like Growth Factor-1/Insulin like Growth Factor Binding Protein 3 administered until 95% wound healing

  • ItraconazoleDrug

    Itraconazole administered until 95% wound healing

  • Growth Hormone and PropranololDrug

    Growth Hormone and Propranolol given until 95% wound healing

  • Oxandrolone and PropranololDrug

    Oxandrolone and Propranolol

  • Placebo or ControlDrug

    Administration of Placebo or Control until 95% wound healing

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Decrease Hypermetabolism as Measured by Stable Isotope Infusion StudyTime frame: Admission to burn unit to 95% wound healing

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Texas Medical Branch

    Galveston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.